ENRYLAZE sol inj 10 mg/0.5ml 3 flac 0.5 ml
7680690730017
CH-69073
L01XX02
07.16.1.
1 / 3
google
Details
- Product number
- 6907301
- CPT
- -
- Packaging group
- 3
- Unit
- Durchstechflasche(n)
- Composition
- crisantaspasum 10 mg, trehalosum dihydricum, natrii chloridum, dinatrii phosphas, natrii dihydrogenophosphas monohydricus, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 0.5 ml corresp. natrium ca. 1 mg.
Articles (1)
Enrylaze 10 mg/vial, Injektionslösung
Injektionslösung
3
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Authorization holder
Jazz Pharmaceuticals
6300 Zug
Authorization information
- Swissmedic authorization number
- 69073
- Drug name
- Enrylaze, Injektionslösung
- Galenic form
- LSIN
- ATC Code
- L01XX02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 18/04/2024
- Authorization expiration date
- 17/04/2029
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ENRYLAZE sol inj 10 mg/0.5ml 3 flac 0.5 ml
- Description (DE)
- ENRYLAZE Inj Lös 10 mg/0.5ml 3 Durchstf 0.5 ml
- Market launch
- 18/04/2024
- Narcotic (BTM)
- No